A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine
Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications aren...
Ausführliche Beschreibung
Autor*in: |
Judy Illes [verfasserIn] Douglas Sipp [verfasserIn] Erika Kleiderman [verfasserIn] Shelly Benjaminy [verfasserIn] Rosario Isasi [verfasserIn] Geoff Lomax [verfasserIn] Zubin Master [verfasserIn] Jennifer McCormick [verfasserIn] Ubaka Ogbogu [verfasserIn] Vardit Ravitsky [verfasserIn] Julie M. Robillard [verfasserIn] Fabio Rossi [verfasserIn] Brenda Wilson [verfasserIn] Amy Zarzeczny [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Übergeordnetes Werk: |
In: npj Regenerative Medicine - Nature Portfolio, 2017, 2(2017), 1, Seite 4 |
---|---|
Übergeordnetes Werk: |
volume:2 ; year:2017 ; number:1 ; pages:4 |
Links: |
---|
DOI / URN: |
10.1038/s41536-017-0026-z |
---|
Katalog-ID: |
DOAJ067897886 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ067897886 | ||
003 | DE-627 | ||
005 | 20230502141207.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41536-017-0026-z |2 doi | |
035 | |a (DE-627)DOAJ067897886 | ||
035 | |a (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Judy Illes |e verfasserin |4 aut | |
245 | 1 | 2 | |a A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. | ||
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Douglas Sipp |e verfasserin |4 aut | |
700 | 0 | |a Erika Kleiderman |e verfasserin |4 aut | |
700 | 0 | |a Shelly Benjaminy |e verfasserin |4 aut | |
700 | 0 | |a Rosario Isasi |e verfasserin |4 aut | |
700 | 0 | |a Geoff Lomax |e verfasserin |4 aut | |
700 | 0 | |a Zubin Master |e verfasserin |4 aut | |
700 | 0 | |a Jennifer McCormick |e verfasserin |4 aut | |
700 | 0 | |a Ubaka Ogbogu |e verfasserin |4 aut | |
700 | 0 | |a Vardit Ravitsky |e verfasserin |4 aut | |
700 | 0 | |a Julie M. Robillard |e verfasserin |4 aut | |
700 | 0 | |a Fabio Rossi |e verfasserin |4 aut | |
700 | 0 | |a Brenda Wilson |e verfasserin |4 aut | |
700 | 0 | |a Amy Zarzeczny |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t npj Regenerative Medicine |d Nature Portfolio, 2017 |g 2(2017), 1, Seite 4 |w (DE-627)876318367 |w (DE-600)2879698-6 |x 20573995 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2017 |g number:1 |g pages:4 |
856 | 4 | 0 | |u https://doi.org/10.1038/s41536-017-0026-z |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1038/s41536-017-0026-z |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2057-3995 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 2 |j 2017 |e 1 |h 4 |
author_variant |
j i ji d s ds e k ek s b sb r i ri g l gl z m zm j m jm u o uo v r vr j m r jmr f r fr b w bw a z az |
---|---|
matchkey_str |
article:20573995:2017----::bupitoteeteeainflieerhriignotec |
hierarchy_sort_str |
2017 |
publishDate |
2017 |
allfields |
10.1038/s41536-017-0026-z doi (DE-627)DOAJ067897886 (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 DE-627 ger DE-627 rakwb eng Judy Illes verfasserin aut A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. Medicine R Douglas Sipp verfasserin aut Erika Kleiderman verfasserin aut Shelly Benjaminy verfasserin aut Rosario Isasi verfasserin aut Geoff Lomax verfasserin aut Zubin Master verfasserin aut Jennifer McCormick verfasserin aut Ubaka Ogbogu verfasserin aut Vardit Ravitsky verfasserin aut Julie M. Robillard verfasserin aut Fabio Rossi verfasserin aut Brenda Wilson verfasserin aut Amy Zarzeczny verfasserin aut In npj Regenerative Medicine Nature Portfolio, 2017 2(2017), 1, Seite 4 (DE-627)876318367 (DE-600)2879698-6 20573995 nnns volume:2 year:2017 number:1 pages:4 https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 kostenfrei https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/toc/2057-3995 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2017 1 4 |
spelling |
10.1038/s41536-017-0026-z doi (DE-627)DOAJ067897886 (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 DE-627 ger DE-627 rakwb eng Judy Illes verfasserin aut A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. Medicine R Douglas Sipp verfasserin aut Erika Kleiderman verfasserin aut Shelly Benjaminy verfasserin aut Rosario Isasi verfasserin aut Geoff Lomax verfasserin aut Zubin Master verfasserin aut Jennifer McCormick verfasserin aut Ubaka Ogbogu verfasserin aut Vardit Ravitsky verfasserin aut Julie M. Robillard verfasserin aut Fabio Rossi verfasserin aut Brenda Wilson verfasserin aut Amy Zarzeczny verfasserin aut In npj Regenerative Medicine Nature Portfolio, 2017 2(2017), 1, Seite 4 (DE-627)876318367 (DE-600)2879698-6 20573995 nnns volume:2 year:2017 number:1 pages:4 https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 kostenfrei https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/toc/2057-3995 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2017 1 4 |
allfields_unstemmed |
10.1038/s41536-017-0026-z doi (DE-627)DOAJ067897886 (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 DE-627 ger DE-627 rakwb eng Judy Illes verfasserin aut A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. Medicine R Douglas Sipp verfasserin aut Erika Kleiderman verfasserin aut Shelly Benjaminy verfasserin aut Rosario Isasi verfasserin aut Geoff Lomax verfasserin aut Zubin Master verfasserin aut Jennifer McCormick verfasserin aut Ubaka Ogbogu verfasserin aut Vardit Ravitsky verfasserin aut Julie M. Robillard verfasserin aut Fabio Rossi verfasserin aut Brenda Wilson verfasserin aut Amy Zarzeczny verfasserin aut In npj Regenerative Medicine Nature Portfolio, 2017 2(2017), 1, Seite 4 (DE-627)876318367 (DE-600)2879698-6 20573995 nnns volume:2 year:2017 number:1 pages:4 https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 kostenfrei https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/toc/2057-3995 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2017 1 4 |
allfieldsGer |
10.1038/s41536-017-0026-z doi (DE-627)DOAJ067897886 (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 DE-627 ger DE-627 rakwb eng Judy Illes verfasserin aut A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. Medicine R Douglas Sipp verfasserin aut Erika Kleiderman verfasserin aut Shelly Benjaminy verfasserin aut Rosario Isasi verfasserin aut Geoff Lomax verfasserin aut Zubin Master verfasserin aut Jennifer McCormick verfasserin aut Ubaka Ogbogu verfasserin aut Vardit Ravitsky verfasserin aut Julie M. Robillard verfasserin aut Fabio Rossi verfasserin aut Brenda Wilson verfasserin aut Amy Zarzeczny verfasserin aut In npj Regenerative Medicine Nature Portfolio, 2017 2(2017), 1, Seite 4 (DE-627)876318367 (DE-600)2879698-6 20573995 nnns volume:2 year:2017 number:1 pages:4 https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 kostenfrei https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/toc/2057-3995 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2017 1 4 |
allfieldsSound |
10.1038/s41536-017-0026-z doi (DE-627)DOAJ067897886 (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 DE-627 ger DE-627 rakwb eng Judy Illes verfasserin aut A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. Medicine R Douglas Sipp verfasserin aut Erika Kleiderman verfasserin aut Shelly Benjaminy verfasserin aut Rosario Isasi verfasserin aut Geoff Lomax verfasserin aut Zubin Master verfasserin aut Jennifer McCormick verfasserin aut Ubaka Ogbogu verfasserin aut Vardit Ravitsky verfasserin aut Julie M. Robillard verfasserin aut Fabio Rossi verfasserin aut Brenda Wilson verfasserin aut Amy Zarzeczny verfasserin aut In npj Regenerative Medicine Nature Portfolio, 2017 2(2017), 1, Seite 4 (DE-627)876318367 (DE-600)2879698-6 20573995 nnns volume:2 year:2017 number:1 pages:4 https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 kostenfrei https://doi.org/10.1038/s41536-017-0026-z kostenfrei https://doaj.org/toc/2057-3995 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2017 1 4 |
language |
English |
source |
In npj Regenerative Medicine 2(2017), 1, Seite 4 volume:2 year:2017 number:1 pages:4 |
sourceStr |
In npj Regenerative Medicine 2(2017), 1, Seite 4 volume:2 year:2017 number:1 pages:4 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Medicine R |
isfreeaccess_bool |
true |
container_title |
npj Regenerative Medicine |
authorswithroles_txt_mv |
Judy Illes @@aut@@ Douglas Sipp @@aut@@ Erika Kleiderman @@aut@@ Shelly Benjaminy @@aut@@ Rosario Isasi @@aut@@ Geoff Lomax @@aut@@ Zubin Master @@aut@@ Jennifer McCormick @@aut@@ Ubaka Ogbogu @@aut@@ Vardit Ravitsky @@aut@@ Julie M. Robillard @@aut@@ Fabio Rossi @@aut@@ Brenda Wilson @@aut@@ Amy Zarzeczny @@aut@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
876318367 |
id |
DOAJ067897886 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ067897886</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502141207.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/s41536-017-0026-z</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ067897886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Judy Illes</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Douglas Sipp</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Erika Kleiderman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shelly Benjaminy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rosario Isasi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Geoff Lomax</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zubin Master</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jennifer McCormick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ubaka Ogbogu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vardit Ravitsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Julie M. Robillard</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fabio Rossi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Brenda Wilson</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amy Zarzeczny</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">npj Regenerative Medicine</subfield><subfield code="d">Nature Portfolio, 2017</subfield><subfield code="g">2(2017), 1, Seite 4</subfield><subfield code="w">(DE-627)876318367</subfield><subfield code="w">(DE-600)2879698-6</subfield><subfield code="x">20573995</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41536-017-0026-z</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41536-017-0026-z</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2057-3995</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2017</subfield><subfield code="e">1</subfield><subfield code="h">4</subfield></datafield></record></collection>
|
author |
Judy Illes |
spellingShingle |
Judy Illes misc Medicine misc R A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
authorStr |
Judy Illes |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)876318367 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
20573995 |
topic_title |
A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
topic |
misc Medicine misc R |
topic_unstemmed |
misc Medicine misc R |
topic_browse |
misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
npj Regenerative Medicine |
hierarchy_parent_id |
876318367 |
hierarchy_top_title |
npj Regenerative Medicine |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)876318367 (DE-600)2879698-6 |
title |
A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
ctrlnum |
(DE-627)DOAJ067897886 (DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1 |
title_full |
A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
author_sort |
Judy Illes |
journal |
npj Regenerative Medicine |
journalStr |
npj Regenerative Medicine |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
txt |
container_start_page |
4 |
author_browse |
Judy Illes Douglas Sipp Erika Kleiderman Shelly Benjaminy Rosario Isasi Geoff Lomax Zubin Master Jennifer McCormick Ubaka Ogbogu Vardit Ravitsky Julie M. Robillard Fabio Rossi Brenda Wilson Amy Zarzeczny |
container_volume |
2 |
format_se |
Elektronische Aufsätze |
author-letter |
Judy Illes |
doi_str_mv |
10.1038/s41536-017-0026-z |
author2-role |
verfasserin |
title_sort |
blueprint for the next generation of elsi research, training, and outreach in regenerative medicine |
title_auth |
A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
abstract |
Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. |
abstractGer |
Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. |
abstract_unstemmed |
Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1 |
title_short |
A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine |
url |
https://doi.org/10.1038/s41536-017-0026-z https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1 https://doaj.org/toc/2057-3995 |
remote_bool |
true |
author2 |
Douglas Sipp Erika Kleiderman Shelly Benjaminy Rosario Isasi Geoff Lomax Zubin Master Jennifer McCormick Ubaka Ogbogu Vardit Ravitsky Julie M. Robillard Fabio Rossi Brenda Wilson Amy Zarzeczny |
author2Str |
Douglas Sipp Erika Kleiderman Shelly Benjaminy Rosario Isasi Geoff Lomax Zubin Master Jennifer McCormick Ubaka Ogbogu Vardit Ravitsky Julie M. Robillard Fabio Rossi Brenda Wilson Amy Zarzeczny |
ppnlink |
876318367 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1038/s41536-017-0026-z |
up_date |
2024-07-03T14:42:46.934Z |
_version_ |
1803569350013091840 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ067897886</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502141207.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/s41536-017-0026-z</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ067897886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJeb33685db50148e6b88a030ba2f5a6e1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Judy Illes</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Douglas Sipp</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Erika Kleiderman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shelly Benjaminy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rosario Isasi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Geoff Lomax</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zubin Master</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jennifer McCormick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ubaka Ogbogu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vardit Ravitsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Julie M. Robillard</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fabio Rossi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Brenda Wilson</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Amy Zarzeczny</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">npj Regenerative Medicine</subfield><subfield code="d">Nature Portfolio, 2017</subfield><subfield code="g">2(2017), 1, Seite 4</subfield><subfield code="w">(DE-627)876318367</subfield><subfield code="w">(DE-600)2879698-6</subfield><subfield code="x">20573995</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41536-017-0026-z</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/eb33685db50148e6b88a030ba2f5a6e1</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41536-017-0026-z</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2057-3995</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2017</subfield><subfield code="e">1</subfield><subfield code="h">4</subfield></datafield></record></collection>
|
score |
7.4003057 |